Novartis Investigative Site

Bogalusa, Louisiana 70427

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a), Diabetes Mellitus and Heart Failure

Studies at this site

• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure — Stopped early